BenchlingPRIVATE · FOUNDED 2013
SignosPRIVATE · FOUNDED 2016Each bar is the last disclosed mark — $6.1B for Benchling (post-money, Nov 2021) and $1B for Signos (post-money, May 2026).


BenchlingPRIVATEHealth · US · 2013
SignosPRIVATEHealth · US · 2016
The $6.1B tells you…
The $1B tells you…Both marks are post-money, so 6.10× compares like with like. Both are private: there is no public quote and no Canborsa market on either name.
Benchling's sector is Biotech/Research Software; Signos' sector is HealthTech / Diabetes.
Benchling is valued at $6.1B, and Signos at $1B.
Benchling was founded in 2013, and Signos was founded in 2016.
Benchling employs around 605 people; Signos employs around 200.
Benchling is headquartered in United States, and Signos in United States.